Concepedia

Thomas D’huys

TD

12

Publications

376

Citations

12

H-Index

2015

Active since

Affiliations

Rega Institute for Medical Research(Current)

KU Leuven

University of Hull

Weatherford (United States)

Southwestern Oklahoma State University

Thomas D’huys is an author at Rega Institute for Medical Research specializing in drug discovery, cell biology, and immunotherapy.

ORCID

Top concepts

Publications per year

2015–2022

12

Publications

12

The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications

Stephanie Gordts, Geoffrey Férir, Thomas D’huys et al. · PLoS ONE · 2015 · 71 citations · Full text

Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3

Martyna Szpakowska, Amanda M. Nevins, Max Meyrath et al. · British Journal of Pharmacology · 2017 · 66 citations · Full text

Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors

Anneleen Van Hout, Thomas D’huys, Merel Oeyen et al. · PLoS ONE · 2017 · 49 citations · Full text

, , +21

New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities

Sophie Poty, Pauline Désogère, Christine Goze et al. · Dalton Transactions · 2015 · 36 citations · Full text

<sup>64</sup>Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist

Benjamin P. Burke, Cecilia S. Miranda, Rhiannon E. Lee et al. · Journal of Nuclear Medicine · 2019 · 36 citations · Full text

Rows per page

1–5 of 12